Table 3.
Comparison of renal function indexes between the two groups before and after treatment
| Ligliptin treatment group | Gliquidone treatment group | P value | |
| Number of cases | 54 | 56 | |
| UAER (μg/min) | |||
| Before treatment | 110.21 (18.82) | 107.82 (20.11) | 0.522 |
| After treatment | 70.32 (11.21)a | 88.42 (12.27)a | 0.000 |
| BUN (mmol/L) | |||
| Before treatment | 6.10 (1.12) | 6.05 (1.09) | 0.813 |
| After treatment | 5.77 (1.04)a | 5.79 (1.21)a | 0.926 |
| Cr (μmol/L) | |||
| Before treatment | 110.38 (15.56) | 108.82 (18.81) | 0.637 |
| After treatment | 108.02 (12.38) | 107.22 (11.87) | 0.730 |
| CysC (mg/L) | |||
| Before treatment | 1.74 (0.30) | 1.78 (0.33) | 0.508 |
| After treatment | 1.65 (0.33)a | 1.67 (0.35)a | 0.759 |
a
P < 0.05 vs before treatment. UAER: Urinary albumin excretion rate; BUN: Blood urea nitrogen; Cr: Creatinine; CysC: Cystatin C.